Literature DB >> 4425338

Individualization of drug dosage in patients with renal disease.

L Dettli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4425338     DOI: 10.1016/s0025-7125(16)32094-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  16 in total

1.  Elimination kinetics of sulfadiazine in patients with normal and impaired renal function.

Authors:  E E Ohnhaus; P Spring
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

4.  Formal theory of discrete drug dosing regimen adjustments.

Authors:  I Janků
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Pharmacokinetics of the penicillins in man.

Authors:  M Barza; L Weinstein
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Overestimation of renal function in glucocorticosteroid treated patients.

Authors:  F F Horber; J Scheidegger; F J Frey
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Network pharmacodynamic models for customized cancer therapy.

Authors:  James M Gallo; Marc R Birtwistle
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-04-24

Review 8.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 9.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.

Authors:  L O Erikson; E Wåhlin-Boll; I Odar-Cederlöf; L Lindholm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.